Back to top
more

West Pharmaceutical Services (WST)

(Delayed Data from NYSE)

$349.92 USD

349.92
440,220

+1.44 (0.41%)

Updated Aug 26, 2026 04:02 PM ET

After-Market: $349.92 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (71 out of 247)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

BD Stock Slips in Pre-Market Despite Q4 Earnings Beat, Margins Up

by Zacks Equity Research

BDX tops fourth-quarter fiscal 2025 earnings estimates and posts strong margin gains, with growth across all business segments and geographies.

Zacks Equity Research

Hims & Hers Stock Slips Post Y/Y Q3 Earnings Decline, Margins Contract

by Zacks Equity Research

HIMS reports lower third-quarter 2025 earnings even as revenue and subscriber growth remain strong across its channels.

Zacks Equity Research

MASI Stock Gains Post Q3 Earnings and Revenue Beat, Margins Expand

by Zacks Equity Research

Masimo beats third-quarter 2025 earnings and revenue estimates as operating margins and profits improve on lower expenses.

Zacks Equity Research

INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Expands

by Zacks Equity Research

Inspire Medical tops third-quarter 2025 estimates as revenue climbs and gross margin improves, with full-year EPS guidance raised.

Zacks Equity Research

Zacks Industry Outlook Highlights McKesson, Cardinal, West Pharmaceutical and The Cooper

by Zacks Equity Research

McKesson, Cardinal, West Pharmaceutical and The Cooper have been highlighted in this Industry Outlook article.

Indrajit Bandyopadhyay headshot

4 Resilient Dental Supply Players Positioned to Withstand Tariff Risks

by Indrajit Bandyopadhyay

Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and COO.

Zacks Equity Research

Wall Street Analysts Think West Pharmaceutical (WST) Could Surge 25.41%: Read This Before Placing a Bet

by Zacks Equity Research

The mean of analysts' price targets for West Pharmaceutical (WST) points to a 25.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Equity Research

Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now

by Zacks Equity Research

FMS acquisitions, partnerships and global reach fuel growth, though rising costs weigh on near-term prospects.

Zacks Equity Research

Here's Why You Should Add OPKO Health Stock to Your Portfolio

by Zacks Equity Research

OPK benefits from RAYALDEE momentum, strategic deals and advancing trials amid stiff competition and dependence risks.

Zacks Equity Research

WST Stock Up on Q3 Earnings Beat, EPS View Raised on Demand & FX Benefit

by Zacks Equity Research

West Pharmaceutical's strong Q3 beat and raised EPS outlook highlight robust demand, FX tailwinds, and solid growth in Proprietary Products.